These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 504342)
21. Fluspirilene in the treatment of non-hospitalized schizophrenic patients. Soni SD Curr Med Res Opin; 1977; 4(9):645-9. PubMed ID: 590024 [TBL] [Abstract][Full Text] [Related]
22. Fluspirilene: a long-acting injectable neuroleptic. Drug Ther Bull; 1977 Jul; 15(15):59-60. PubMed ID: 330126 [No Abstract] [Full Text] [Related]
23. Utilization and safety of fluspirilene in nonpsychotic outpatients. Schmidt LG Pharmacopsychiatry; 1989 Sep; 22(5):188-91. PubMed ID: 2813507 [TBL] [Abstract][Full Text] [Related]
24. Clinical experience with fluspirilene in psychoses. Svestka J; Náhunek K; Hádlík J; Rodová A Act Nerv Super (Praha); 1971; 13(3):173-4. PubMed ID: 5113825 [No Abstract] [Full Text] [Related]
25. [Self-rating scales in schizophrenia: validity assessment of the Paranoid-Depression Scale (PD-S), the Frankfurt Self-feeling Scale (FBS) and of two visual analogy scales]. Schaeffer E; Wciórka J Psychiatr Pol; 2003; 37(2):293-314. PubMed ID: 12776660 [TBL] [Abstract][Full Text] [Related]
26. Experimental comparison of low doses of 1.5 mg fluspirilene and bromazepam in out-patients with psychovegetative disturbances. Hassel P Pharmacopsychiatry; 1985 Sep; 18(5):297-302. PubMed ID: 2864709 [TBL] [Abstract][Full Text] [Related]
27. [Fluspirilene in schizophrenia maintenance therapy and its interaction with dexetimide]. Skopová J; Faltus F; Filip V; Jirák R; Karen P; Posmurová M; Dobiásová A Cesk Psychiatr; 1985 Dec; 81(6):414-9. PubMed ID: 3912068 [No Abstract] [Full Text] [Related]
28. [Self-rating scales in schizophrenia: assessment of the practical applicability of the Paranoid-Depression Scale (PD-S), the Frankfurt Self-feeling Scale (FBS) and of two visual analogue scales]. Schaeffer E; Wciórka J Psychiatr Pol; 2003; 37(2):315-35. PubMed ID: 12776661 [TBL] [Abstract][Full Text] [Related]
29. Fluspirilene (Imap) in the treatment of psychosomatic complaints in hypochondriacal patients. Kalis D; Ten Oever GH; Erdmann JF Acta Psychiatr Belg; 1980; 80(3):321-8. PubMed ID: 7211423 [TBL] [Abstract][Full Text] [Related]
30. Clinical and ergotherapeutic evaluation of fluspirilene (R 6218), a long-acting injectable neuroleptic, in chronic psychotic patients. Tanghe A; Vereecken JL Psychiatr Neurol Neurochir; 1971; 74(5):379-89. PubMed ID: 5138128 [No Abstract] [Full Text] [Related]
31. [Alternative therapy concept for the treatment of psychosomatic disorders. Controlled double-blind evaluation of fluspirilene versus bromazepam]. Lehmann E; Hassel P; Thörner GW; Karrass W Fortschr Med; 1984 Oct; 102(40):1033-6. PubMed ID: 6149989 [TBL] [Abstract][Full Text] [Related]
32. [Results with the sustained-action neuroleptic fluspirilene on chronic schizophrenic patients undergoing occupational therapy]. Gálfi B; Benson K; Grynaeus T Int Pharmacopsychiatry; 1973; 8(1):37-59. PubMed ID: 4595192 [No Abstract] [Full Text] [Related]
33. [Leading symptom of anxiety and tension and its concomitant somatic manifestations. A multicenter trial of fluspirilene versus bromazepam]. Thilmann J Fortschr Med; 1983 Oct; 101(37):1676-8. PubMed ID: 6139327 [TBL] [Abstract][Full Text] [Related]
34. Effects and side-effects of bromperidol in comparison with other antipsychotic drugs. Woggon B Acta Psychiatr Belg; 1978; 78(1):155-72. PubMed ID: 347878 [TBL] [Abstract][Full Text] [Related]
35. [Depot neuroleptics in social psychiatric practice]. Pruss U; Rose HK; Zechner A Psychiatr Prax; 1984 Jul; 11(4):101-8. PubMed ID: 6148764 [TBL] [Abstract][Full Text] [Related]
36. Continuation electroconvulsive therapy for relapse prevention in middle-aged and elderly patients with intractable catatonic schizophrenia. Suzuki K; Awata S; Takano T; Ebina Y; Iwasaki H; Matsuoka H Psychiatry Clin Neurosci; 2005 Aug; 59(4):481-9. PubMed ID: 16048455 [TBL] [Abstract][Full Text] [Related]